Industry Dynamic

Nat Rev Cancer A practical guide to artificial intelligence in cancer research

Artificial intelligence has realized commercialization, from professional resources to cancer researchers tool is easy to obtain. Ai-based tools can not only improve research productivity in daily workflows, bu...

[View details]

SFDA: innovation medicine development momentum The first five months of this year has approved the innovation medicine 20

On June 14, The State Council Information Office held a briefing to introduce the key tasks of deepening the medical and health system reform in 2024. Huang Guo, deputy director of the State Food and Drug Admin...

[View details]

Comparison of approved new drugs in China and USA in the first half of 2024

In the first half of 2024, 21 new Class 1 drugs were approved by the Food and Drug Administration (FDA) and 26 new Class 1 drugs were approved by Chinese National Medical Products Administration (NMPA). This ar...

[View details]

Chinese experts originally researched small molecule new drugs and successfully translated the results to the world

After 10 years of painstaking research, the original preclinical small molecule new drugs jointly developed by the research team of East China Normal University and Fudan University in the field of anti-tumor c...

[View details]